by Glenn S. Demby | Oct 3, 2022 | Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Testing Trends-dtet
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
This content is for Paid Members only.
Login Register
by Glenn S. Demby | May 27, 2022 | Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Emerging Tests-dtet
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
This content is for Paid Members only.
Login Register
by Rachel Muenz | May 26, 2022 | Articles , Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Emerging Tests-dtet
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
This content is for Paid Members only.
Login Register
by Glenn S. Demby | Mar 17, 2022 | Articles , Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Recent Headlines , Special Focus-dtet
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
This content is for Paid Members only.
Login Register
by SYNAPS Dx | Mar 2, 2022 | Articles , News , Open Content
ROCKVILLE, MD — The announcement of a recent investment from Semler Scientific (SMLR) in SYNAPS Dx (SDx), a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including...